Cargando…
Nanoparticle Delivery of Immunostimulatory Alu RNA for Cancer Immunotherapy
It was recently found that patients with relapsing remitting multiple sclerosis exhibit widespread loss of adenosine-to-inosine (A-to-I) RNA editing, which contributes to the accumulation of immunostimulatory double-stranded Alu RNA in circulating leukocytes and an attendant increase in levels of pr...
Autores principales: | Garland, Kyle M., Kwiatkowski, Alexander J., Tossberg, John T., Crooke, Philip S., Aune, Thomas M., Wilson, John T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487107/ https://www.ncbi.nlm.nih.gov/pubmed/37691856 http://dx.doi.org/10.1158/2767-9764.CRC-22-0354 |
Ejemplares similares
-
Alu RNA Structural Features Modulate Immune Cell Activation and A-to-I Editing of Alu RNAs Is Diminished in Human Inflammatory Bowel Disease
por: Aune, Thomas M., et al.
Publicado: (2022) -
Reduced A-to-I editing of endogenous Alu RNAs in lung after SARS-CoV-2 infection
por: Crooke, Philip S., et al.
Publicado: (2021) -
Nanoparticle Delivery of Immunostimulatory Agents for Cancer Immunotherapy
por: Zhuang, Jia, et al.
Publicado: (2019) -
Reduced RNA adenosine-to-inosine editing in hippocampus vasculature associated with Alzheimer’s disease
por: Crooke, Philip S, et al.
Publicado: (2022) -
Defective structural RNA processing in relapsing-remitting multiple sclerosis
por: Spurlock, Charles F, et al.
Publicado: (2015)